Structural |
Contrast-enhancing MRI |
Clinical practice |
GBM, CNS metastases |
Vaccine, Cell therapy, Checkpoint blockade, Virus |
14, 49
|
FLAIR MRI |
Clinical practice |
GBM, CNS metastases |
Vaccine, Cell therapy, Checkpoint blockade, Virus |
14, 46, 49
|
Physiological |
DTI MRI |
Clinical practice |
GBM, CNS metastases |
Vaccine, Cell therapy, Checkpoint blockade, Virus |
50 |
Diffusion kurtosis imaging MRI |
Research |
GBM |
DC vaccine |
51 |
q-space imaging MRI |
Research |
Glioma (low grade) |
n/a |
52 |
Neurite orientation dispersion and density index MRI |
Research |
GBM |
n/a |
53-55
|
DSC MRI |
Clinical practice |
GBM, CNS metastases |
Vaccine, Cell therapy, Checkpoint blockade, Virus |
47, 51, 56, 57
|
DCE MRI |
Clinical practice |
GBM, CNS metastases |
Vaccine, Cell therapy, Checkpoint blockade, Virus |
49 |
Arterial spin label MRI |
Research |
GBM |
n/a |
49 |
PET hypoxia |
Research |
GBM |
n/a |
58, 59
|
Molecular |
Amino acid PET |
Research |
GBM, CNS metastases |
Vaccine, Checkpoint blockade |
48, 60
|
Antibody-based PET |
Research |
GBM, CNS metastases |
n/a |
61, 62
|
Proliferation PET |
Research |
GBM, CNS metastases |
Vaccine, Checkpoint blockade |
63 |
PET reporter gene |
Research |
GBM |
Vaccine, Cell therapy, Virus |
64-68
|
MRS |
Research |
GBM |
Cell therapy |
69 |
Immune cell tracking |
PET, MRI, SPECT |
Research/Clinical practice |
GBM |
Vaccine, Cell therapy |
70, 71
|
PRECLINICAL IMAGING TECHNIQUES |
Category of imaging technique |
Imaging modality |
Imaging target |
Disease model |
Immunotherapy category used in studies |
References |
Molecular |
Antibody-based PET |
Effector immune cells proteins |
Syngeneic murine colon or mammary carcinoma |
Checkpoint blockade |
72, 73
|
Peptide-based PET |
Immune cell cytolytic activity |
Syngeneic murine colon carcinoma |
Checkpoint blockade |
74 |
Reporter gene PET |
Transgenic T cells |
Murine acute myeloid sarcoma |
Cell therapy |
75 |
Reporter gene MRS |
Virus-transfected cells |
Orthotopic glioma (rat) |
Virus |
76 |